+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Japanese Encephalitis Vaccines Market 2022-2026

  • ID: 5300886
  • Report
  • May 2022
  • Region: Global, Japan
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The market is driven by the inclusion in national immunization plan, strategic alliances for Japanese encephalitis vaccines development, and the growing number of awareness campaigns

FEATURED COMPANIES

  • Adimmune Corp.
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Inc.
  • Panacea Biotec Ltd.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Japanese encephalitis vaccines market is poised to grow by $58.27 million during 2022-2026, accelerating at a CAGR of 5.98% during the forecast period.

This report on the Japanese encephalitis vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by the inclusion in national immunization plan, strategic alliances for Japanese encephalitis vaccines development, and the growing number of awareness campaigns.

The Japanese encephalitis vaccines market analysis includes the type segment and geographic landscape.

The Japanese encephalitis vaccines market is segmented as below:


By Type

  • Inactivated vaccines
  • Recombinant vaccines
  • Live attenuated vaccines

By Geographical Landscape

  • Asia
  • Rest of World (ROW)
  • Europe
  • North America
This study identifies the novel vaccine technology as one of the prime reasons driving the Japanese encephalitis vaccines market growth during the next few years. Also, strong investments from BRICS in research and growing inbound travel to Asia will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report covers the following areas:
  • Japanese encephalitis vaccines market sizing
  • Japanese encephalitis vaccines market forecast
  • Japanese encephalitis vaccines market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, the report provides a detailed analysis of several leading Japanese encephalitis vaccines market vendors that include Adimmune Corp., Bharat Biotech Ltd., Biological E. Ltd., KM Biologics Co. Ltd., Medigen Inc., Panacea Biotec Ltd., Sanofi, Shandong Hengye Biotechnology Co. Ltd., and Valneva SE. Also, the Japanese encephalitis vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adimmune Corp.
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Inc.
  • Panacea Biotec Ltd.

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Inactivated vaccines - Market size and forecast 2021-2026
Exhibit 28: Chart on Inactivated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Inactivated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Inactivated vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Inactivated vaccines - Year-over-year growth 2021-2026 (%)
5.4 Recombinant vaccines - Market size and forecast 2021-2026
Exhibit 32: Chart on Recombinant vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Recombinant vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Recombinant vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Recombinant vaccines - Year-over-year growth 2021-2026 (%)
5.5 Live attenuated vaccines - Market size and forecast 2021-2026
Exhibit 36: Chart on Live attenuated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Live attenuated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Live attenuated vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Live attenuated vaccines - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Type
Exhibit 40: Market opportunity by Type ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 Asia - Market size and forecast 2021-2026
Exhibit 46: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.4 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 50: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.5 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.6 North America - Market size and forecast 2021-2026
Exhibit 58: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.7 China - Market size and forecast 2021-2026
Exhibit 62: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on China - Year-over-year growth 2021-2026 (%)
7.8 India - Market size and forecast 2021-2026
Exhibit 66: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on India - Year-over-year growth 2021-2026 (%)
7.9 Japan - Market size and forecast 2021-2026
Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.10 Republic of Korea - Market size and forecast 2021-2026
Exhibit 74: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
7.11 Australia - Market size and forecast 2021-2026
Exhibit 78: Chart on Australia - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Australia - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Australia - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Australia - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Adimmune Corp.
Exhibit 89: Adimmune Corp. - Overview
Exhibit 90: Adimmune Corp. - Business segments
Exhibit 91: Adimmune Corp. - Key news
Exhibit 92: Adimmune Corp. - Key offerings
Exhibit 93: Adimmune Corp. - Segment focus
10.4 Bharat Biotech Ltd.
Exhibit 94: Bharat Biotech Ltd. - Overview
Exhibit 95: Bharat Biotech Ltd. - Product / Service
Exhibit 96: Bharat Biotech Ltd. - Key news
Exhibit 97: Bharat Biotech Ltd. - Key offerings
10.5 Biological E. Ltd.
Exhibit 98: Biological E. Ltd. - Overview
Exhibit 99: Biological E. Ltd. - Product / Service
Exhibit 100: Biological E. Ltd. - Key news
Exhibit 101: Biological E. Ltd. - Key offerings
10.6 KM Biologics Co. Ltd.
Exhibit 102: KM Biologics Co. Ltd. - Overview
Exhibit 103: KM Biologics Co. Ltd. - Product / Service
Exhibit 104: KM Biologics Co. Ltd. - Key offerings
10.7 Medigen Inc.
Exhibit 105: Medigen Inc. - Overview
Exhibit 106: Medigen Inc. - Product / Service
Exhibit 107: Medigen Inc. - Key offerings
10.8 Panacea Biotec Ltd.
Exhibit 108: Panacea Biotec Ltd. - Overview
Exhibit 109: Panacea Biotec Ltd. - Product / Service
Exhibit 110: Panacea Biotec Ltd. - Key offerings
10.9 Sanofi
Exhibit 111: Sanofi - Overview
Exhibit 112: Sanofi - Business segments
Exhibit 113: Sanofi - Key news
Exhibit 114: Sanofi - Key offerings
Exhibit 115: Sanofi - Segment focus
10.10 Shandong Hengye Biotechnology Co. Ltd.
Exhibit 116: Shandong Hengye Biotechnology Co. Ltd. - Overview
Exhibit 117: Shandong Hengye Biotechnology Co. Ltd. - Product / Service
Exhibit 118: Shandong Hengye Biotechnology Co. Ltd. - Key offerings
10.11 Valneva SE
Exhibit 119: Valneva SE - Overview
Exhibit 120: Valneva SE - Business segments
Exhibit 121: Valneva SE - Key offerings
Exhibit 122: Valneva SE - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 123: Inclusions checklist
Exhibit 124: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 125: Currency conversion rates for US$
11.4 Research methodology
Exhibit 126: Research methodology
Exhibit 127: Validation techniques employed for market sizing
Exhibit 128: Information sources
11.5 List of abbreviations
Exhibit 129: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Incremental Growth
Exhibit 7: Executive Summary - Data Table on Incremental Growth
Exhibit 8: Executive Summary - Chart on Vendor Market Positioning
Exhibit 9: Parent market
Exhibit 10: Market Characteristics
Exhibit 11: Offerings of vendors included in the market definition
Exhibit 12: Market segments
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
Exhibit 28: Chart on Inactivated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Inactivated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Inactivated vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Inactivated vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 32: Chart on Recombinant vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Recombinant vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Recombinant vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Recombinant vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 36: Chart on Live attenuated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Live attenuated vaccines - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Live attenuated vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Live attenuated vaccines - Year-over-year growth 2021-2026 (%)
Exhibit 40: Market opportunity by Type ($ million)
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
Exhibit 46: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 50: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 58: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibit 62: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibit 66: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 74: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibit 78: Chart on Australia - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Australia - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Australia - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Australia - Year-over-year growth 2021-2026 (%)
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
Exhibit 85: Overview on factors of disruption
Exhibit 86: Impact of key risks on business
Exhibit 87: Vendors covered
Exhibit 88: Matrix on vendor position and classification
Exhibit 89: Adimmune Corp. - Overview
Exhibit 90: Adimmune Corp. - Business segments
Exhibit 91: Adimmune Corp. - Key news
Exhibit 92: Adimmune Corp. - Key offerings
Exhibit 93: Adimmune Corp. - Segment focus
Exhibit 94: Bharat Biotech Ltd. - Overview
Exhibit 95: Bharat Biotech Ltd. - Product / Service
Exhibit 96: Bharat Biotech Ltd. - Key news
Exhibit 97: Bharat Biotech Ltd. - Key offerings
Exhibit 98: Biological E. Ltd. - Overview
Exhibit 99: Biological E. Ltd. - Product / Service
Exhibit 100: Biological E. Ltd. - Key news
Exhibit 101: Biological E. Ltd. - Key offerings
Exhibit 102: KM Biologics Co. Ltd. - Overview
Exhibit 103: KM Biologics Co. Ltd. - Product / Service
Exhibit 104: KM Biologics Co. Ltd. - Key offerings
Exhibit 105: Medigen Inc. - Overview
Exhibit 106: Medigen Inc. - Product / Service
Exhibit 107: Medigen Inc. - Key offerings
Exhibit 108: Panacea Biotec Ltd. - Overview
Exhibit 109: Panacea Biotec Ltd. - Product / Service
Exhibit 110: Panacea Biotec Ltd. - Key offerings
Exhibit 111: Sanofi - Overview
Exhibit 112: Sanofi - Business segments
Exhibit 113: Sanofi - Key news
Exhibit 114: Sanofi - Key offerings
Exhibit 115: Sanofi - Segment focus
Exhibit 116: Shandong Hengye Biotechnology Co. Ltd. - Overview
Exhibit 117: Shandong Hengye Biotechnology Co. Ltd. - Product / Service
Exhibit 118: Shandong Hengye Biotechnology Co. Ltd. - Key offerings
Exhibit 119: Valneva SE - Overview
Exhibit 120: Valneva SE - Business segments
Exhibit 121: Valneva SE - Key offerings
Exhibit 122: Valneva SE - Segment focus
Exhibit 123: Inclusions checklist
Exhibit 124: Exclusions checklist
Exhibit 125: Currency conversion rates for US$
Exhibit 126: Research methodology
Exhibit 127: Validation techniques employed for market sizing
Exhibit 128: Information sources
Exhibit 129: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adimmune Corp.
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Inc.
  • Panacea Biotec Ltd.
The analyst recognizes the following companies as the key players in the global Japanese encephalitis vaccines market: Adimmune Corp., Bharat Biotech Ltd., Biological E. Ltd., KM Biologics Co. Ltd., Medigen Inc., Panacea Biotec Ltd., Sanofi, Shandong Hengye Biotechnology Co. Ltd., and Valneva SE.

Commenting on the report, an analyst said: ''The latest trend gaining momentum in the market is novel vaccine technology.''

According to the report, one of the major drivers for this market is the inclusion in national immunization plan.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Adimmune Corp.
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Inc.
  • Panacea Biotec Ltd.
  • Sanofi
  • Shandong Hengye Biotechnology Co. Ltd.
  • Valneva SE
Note: Product cover images may vary from those shown